Videos

Marlies
Vanden Bempt
KU Leuven
VIB

Immunotherapy: why screening patients is key

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.
Matteo
Rossi
FWO
KU Leuven
VIB

Finding the weak spot of breast cancer cells

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.
Ovia Margaret
Thirukkumaran
FWO
KU Leuven

HER2 breast cancer: comprehend to conquer it!

Did you know that breast cancer is the second most common cancer for women, affecting 1.7 million women worldwide? In her research Ovia Margaret Thirukkumaran is trying to decipher how cancer cells communicate and develop resistance against drugs in so called HER 2 breast cancer, a very aggressive form of breast cancer.
Nena
Testelmans
KU Leuven
VIB

Organ transplants: life-saving, yet sometimes lethal

While an organ transplant will often save the life of a patient, it also leads to a higher risk of developing cancer. Nena Testelmans (KU Leuven) is determined to help unravel why transplants might induce cancer in patients.